David Epstein, Division Head of Novartis Pharmaceuticals, spoke with Fair360, formerly DiversityInc CEO Luke Visconti at Novartis corporate headquarters in Basel, Switzerland, about how diversity impacts innovation, R&D and marketing.Novartis Pharmaceuticals Corporation is No. 13 on the Fair360, formerly DiversityInc Top 50.
LUKE VISCONTI: What led you to be a supporter of diversity and inclusion How has it impacted the success of your business units
DAVID EPSTEIN: There are two drivers for me. One is that I grew up in an atmosphere my parents created where people are people, regardless of whether they’re male, female, from any given country, religious background or sexual orientation. I’m interested in what a person can contribute, what their unique experiences are.
